ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Lupin announces achievement of key milestones for its clinical stage MEK inhibitor compound
May 31, 2021Lupin’s MEK inhibitor compound is planned for clinical development in combination with Boehringer Ingelheim’s KRAS inhibitor pipeline to address KRAS-driven cancers. -
Cancer-killing virus plus PD-1 and MEK inhibitors make for a 3-pronged attack on melanoma
December 26, 2018When Amgen’s cancer-killing virus Imlygic—also known as T-Vec—was approved by the FDA in late 2015, experts expected it would work best in combination strategies for melanoma.....
Pharma Sources Insight January 2025
